Decheng Capital Global Life Sciences Fund IV, L.P.
SEC CIK 1834150 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AARD | Aardvark Therapeutics, Inc. | 10% | 333.4K | $20.00M | — | 2 | 2025-02-14 | 2025-02-14 |
Most active insiders at AARD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sun Nelson | See Remarks | $43.2K | $395.0K |
| 2 | Lee Tien-Li | CEO, Dir, 10% | $101.4K | — |
| 3 | Jones Bryan | COO | — | — |
Decheng Capital Global Life Sciences Fund IV, L.P. made no open-market trades at AARD in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2025-02-19 | 2025-02-14 | AARD | Aardvark Therapeutics, Inc. | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% | C - Cnv Deriv | — | +2.67M | 333.4K | New | — |
| DMI | 2025-02-19 | 2025-02-14 | AARD | Aardvark Therapeutics, Inc. | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% | P - Purchase | $16.00 | +1.25M | 2.96M | +73% | +$20.00M |
Purchase Sale Sale after option exercise All abbreviations